Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Endocrine Reviews · 11.07.2023 · 44 (4) · 567-628
DOI: 10.1210/endrev/bnac034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Reviews, online erschienen am 22.12.2022. Verfasst von Jérôme Bertherat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Cochin Hospital, Assistance Publique Hôpitaux de Paris, 24 rue …. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Cushing Syndrome. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 427 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale, CARPEM.
Abstract (Originalsprache)
Patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) usually present bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol excess. PBMAH is a rare cause of primary overt Cushing's syndrome but may represent up to one-third of bilateral adrenal incidentalomas with evidence of cortisol excess. The increased steroidogenesis in PBMAH is often regulated by various G protein–coupled receptors (GPCRs) aberrantly expressed in PBMAH tissues; some receptor ligands are ectopically produced in PBMAH tissues, creating aberrant autocrine/paracrine regulation of steroidogenesis. The bilateral nature of PBMAH and familial aggregation led to the identification of germline heterozygous inactivating mutations of the ARMC5 gene, in 20% to 25% of the apparent sporadic cases and more frequently in familial cases; ARMC5 mutations/pathogenic variants can be associated with meningiomas. More recently, combined germline mutations/pathogenic variants and somatic events inactivating the KDM1A gene were specifically identified in patients affected by glucose-dependent insulinotropic peptide (GIP)-dependent PBMAH. Functional studies demonstrated that inactivation of KDM1A leads to GIP-receptor (GIPR) overexpression and over- or downregulation of other GPCRs. Genetic analysis is now available for early detection of family members of index cases with PBMAH carrying identified germline pathogenic variants. Detailed biochemical, imaging, and comorbidity assessment of the nature and severity of PBMAH is essential for its management. Treatment is reserved for patients with overt or mild cortisol/aldosterone or other steroid excesses, taking in account comorbidities. It previously relied on bilateral adrenalectomy; however, recent studies tend to favor unilateral adrenalectomy or, less frequently, medical treatment with cortisol synthesis inhibitors or specific blockers of aberrant GPCR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Cochin Hospital, Assistance Publique Hôpitaux de Paris, 24 rue du Fg St Jacques, 75014 Paris, France.
- Division of Endocrinology, Department of Medicine and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec H2X 0A9, Canada.
- Service d'Endocrinologie et des Maladies de la Reproduction Université, Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes, 94276 Le Kremlin-Bicêtre, France.
ORCID-Profile: Isabelle Bourdeau, André Lacroix
Förderung
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- CARPEM
- Fondation ARC
Zitieren
APA
Bertherat, J., Bourdeau, I., Bouys, L., Chasseloup, F., Kamenický, P., & Lacroix, A. (2023). Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia. Endocrine Reviews, 44(4), 567-628. https://doi.org/10.1210/endrev/bnac034
Vancouver
Bertherat J, Bourdeau I, Bouys L, Chasseloup F, Kamenický P, Lacroix A. Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia. Endocrine Reviews. 2023;44(4):567-628. doi:10.1210/endrev/bnac034
BibTeX
@article{Bertherat2023,
author = {Bertherat, Jérôme and Bourdeau, Isabelle and Bouys, Lucas and Chasseloup, Fanny and Kamenický, Peter and Lacroix, André},
title = {Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia},
journal = {Endocrine Reviews},
year = {2023},
volume = {44},
number = {4},
pages = {567--628},
doi = {10.1210/endrev/bnac034}
}
EUVIMED